Histological features associated with relapse after corticosteroid withdrawal in type 1 autoimmune hepatitis
- 24 March 2003
- journal article
- research article
- Published by Wiley in Liver International
- Vol. 23 (2) , 116-123
- https://doi.org/10.1034/j.1600-0676.2003.00810.x
Abstract
Relapse of type 1 autoimmune hepatitis after drug withdrawal may relate to incomplete histological improvement during corticosteroid therapy and/or persistence of pathogenic mechanisms. Aim: Determine the histological features prior to drug withdrawal that are associated with relapse in patients satisfying pre‐established clinical, laboratory, and histological criteria for remission and relapsing after corticosteroid withdrawal. Methods: One hundred liver tissue samples obtained immediately prior to corticosteroid withdrawal from 88 patients who had previously satisfied criteria for histological remission were reviewed retrospectively. Results: Histological findings in the patients who relapsed were similar to those in the patients who sustained remission in regard to histological activity index (1.7 ± 0.1 versus 1.6 ± 0.2, P = 0.6), fibrosis score (2.6 ± 0.3 versus 2.3 ± 0.4, P = 0.5), and frequencies of interface hepatitis (36% versus 20%, P = 0.2), cirrhosis (21% versus 17%, P = 0.8), and normal or near normal tissue (9% versus 7%, P > 0.9). Only the presence of portal plasma cells was associated with relapse (31% versus 7%, P = 0.01). The positive predictability of portal plasma cell infiltration for relapse was 92%, but its sensitivity was only 31%. Conclusions: Portal plasma cell infiltration is predictive of relapse after drug withdrawal in tissue specimens already satisfying criteria for remission. Portal plasma cell infiltration may be indicative of an active antibody‐dependent pathogenic mechanism. Its low sensitivity for relapse indicates the need for other complementary predictors of outcome.Keywords
This publication has 44 references indexed in Scilit:
- Sustained remission after corticosteroid therapy for type 1 autoimmune hepatitis: A retrospective analysisHepatology, 2002
- International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitisJournal of Hepatology, 1999
- Frequency and significance of antibodies to asialoglycoprotein receptor in type 1 autoimmune hepatitisDigestive Diseases and Sciences, 1996
- Histological grading and staging of chronic hepatitisJournal of Hepatology, 1995
- Autoimmune hepatitisDigestive Diseases and Sciences, 1995
- Th1 and Th2 CD4+ T cells in the pathogenesis of organ-specific autoimmune diseasesImmunology Today, 1995
- Phenotypical analysis and cytokine release of liver‐infiltrating and peripheral blood T lymphocytes from patients with chronic hepatitis of different etiologyLiver International, 1994
- Effect of Corticosteroids on Suppressor-Cell Activity in Autoimmune and Viral Chronic Active HepatitisNew England Journal of Medicine, 1982
- Corticosteroid-Treated Chronic Active Hepatitis in RemissionNew England Journal of Medicine, 1981
- Detection of Antibodies Directed against a Liver-Specific Membrane Lipoprotein in Patients with Acute and Chronic Active HepatitisNew England Journal of Medicine, 1978